Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC

Simple item page
dc.conference.dateNOV 20-22, 2020
dc.conference.titleESMO Asia Virtual Congress
dc.contributor.authorNishio, M.
dc.contributor.authorBarlesi, F.
dc.contributor.authorBall, S.
dc.contributor.authorBordoni, R.
dc.contributor.authorCobo, M.
dc.contributor.authorDubray-Longeras, P.
dc.contributor.authorGoldschmidt, J.
dc.contributor.authorNovello, S.
dc.contributor.authorOrlandi, F. J.
dc.contributor.authorSanborn, R.
dc.contributor.authorSzalai, Z.
dc.contributor.authorUrsol, G.
dc.contributor.authorMendus, D.
dc.contributor.authorWang, L.
dc.contributor.authorWen, X.
dc.contributor.authorMcCleland, M.
dc.contributor.authorHoang, T.
dc.contributor.authorPhan, S.
dc.contributor.authorSocinski, M.
dc.contributor.authoraffiliation[Nishio, M.] Japanese Fdn Canc Res, Canc Inst Hosp, Thorac Med Oncol, Tokyo, Japan
dc.contributor.authoraffiliation[Barlesi, F.] Aix Marseille Univ, Multidisciplinary Oncol & Therapeut Innovat, CNRS, INSERM,CRCM,APHM, Marseille, France
dc.contributor.authoraffiliation[Ball, S.] Queens Hosp, Oncol, Romford, Essex, England
dc.contributor.authoraffiliation[Bordoni, R.] Northside Hosp Canc Inst, Med Oncol, Atlanta, GA USA
dc.contributor.authoraffiliation[Cobo, M.] Reg Univ Hosp Malaga, Med Oncol, IBIMA, Malaga, Spain
dc.contributor.authoraffiliation[Dubray-Longeras, P.] Ctr Jean Perrin, Med Oncol, Clermont Ferrand, France
dc.contributor.authoraffiliation[Goldschmidt, J.] Blue Ridge Canc Care, Med Oncol, Blue, VA USA
dc.contributor.authoraffiliation[Novello, S.] Univ Turin, Oncol, Orbassano, Italy
dc.contributor.authoraffiliation[Orlandi, F. J.] Inst Nacl Torax, Lung Canc Unit, Med Oncol, Santiago, Chile
dc.contributor.authoraffiliation[Sanborn, R.] Earle A Chiles Res Inst, Providence Canc Inst, Med Oncol, Portland, OR USA
dc.contributor.authoraffiliation[Szalai, Z.] Petz Aladar Cty Teaching Hosp, Pulmonol, Gyor, Hungary
dc.contributor.authoraffiliation[Ursol, G.] Med & Diagnost Ctr, Acinus, Kropyvnytskyi, Ukraine
dc.contributor.authoraffiliation[Mendus, D.] Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA
dc.contributor.authoraffiliation[Hoang, T.] Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA
dc.contributor.authoraffiliation[Phan, S.] Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA
dc.contributor.authoraffiliation[Wang, L.] Genentech Inc, Biostat, San Francisco, CA 94080 USA
dc.contributor.authoraffiliation[Wen, X.] Genentech Inc, Prod Dev Safety, San Francisco, CA 94080 USA
dc.contributor.authoraffiliation[McCleland, M.] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA
dc.contributor.authoraffiliation[Socinski, M.] AdventHealth Canc Inst, Thorac Oncol, Orlando, FL USA
dc.contributor.funderF. Hoffmann-La Roche, Ltd.
dc.date.accessioned2025-01-07T12:18:48Z
dc.date.available2025-01-07T12:18:48Z
dc.date.issued2020-11-01
dc.identifier.doi10.1016/j.annonc.2020.10.369
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420428601/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24446
dc.identifier.wosID600988900379
dc.issue.number6
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.numberS1386-S1387
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleFinal efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía